AMAG Pharmaceuticals Net debt/EBITDA
What is the Net debt/EBITDA of AMAG Pharmaceuticals?
The Net debt/EBITDA of AMAG Pharmaceuticals, Inc. is -5.97
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with net debt/ebitda similar to AMAG Pharmaceuticals
- XLMedia PLC has Net debt/EBITDA of -5.99
- SEI Investments Co has Net debt/EBITDA of -5.99
- Beng Soon Mach Hldg Ltd has Net debt/EBITDA of -5.98
- Pacific Silk Road Resources has Net debt/EBITDA of -5.98
- Wipro has Net debt/EBITDA of -5.98
- MainStreet Bancshares Inc has Net debt/EBITDA of -5.97
- AMAG Pharmaceuticals has Net debt/EBITDA of -5.97
- Eildon Capital Fund has Net debt/EBITDA of -5.97
- CYREN Ltd has Net debt/EBITDA of -5.97
- Evolis SA has Net debt/EBITDA of -5.95
- Industria de Diseño Textil SA has Net debt/EBITDA of -5.95
- VersaBank has Net debt/EBITDA of -5.94
- 3P Learning has Net debt/EBITDA of -5.94